Structural and functional results of indirect diode laser treatment for retinopathy of prematurity from 1999 to 2003 in Kuwait
- PMID: 23403936
- PMCID: PMC3569374
- DOI: 10.2147/OPTH.S38915
Structural and functional results of indirect diode laser treatment for retinopathy of prematurity from 1999 to 2003 in Kuwait
Abstract
Purpose: The purpose was to report the structural, visual, and refractive outcomes of infants treated for retinopathy of prematurity (ROP) with laser and to identify the risk factors for unfavorable outcomes.
Materials and methods: The charts of infants with severe ROP treated by diode laser in a tertiary center during the period April 1999 to November 2003 were reviewed. Treated infants were followed up for fundus examination, visual acuity assessment, and cycloplegic refraction. Data regarding ocular risk factors, like zones of ROP and the extent of extraretinal proliferations, and data regarding various systemic risk factors were collected. A minimum follow up of 6 months was needed for inclusion in the study of structural outcome. A minimum follow up of 24 months was needed for the study of visual and refractive outcomes. The outcomes measured were: rate of unfavorable structural outcome, unfavorable visual outcome (visual acuity < 20/40), and high myopia (myopia ≥ 5 diopters). The ocular and systemic risk factors were studied for their significance in the development of unfavorable outcomes.
Results: Two hundred seventy eyes of 148 infants were treated for severe ROP, out of which 20 eyes (7.4%) had unfavorable structural outcome. Visual data were available for 149 eyes of 81 infants, of which 70 eyes (47%) had unfavorable visual outcome. Refractive data were available for 131 eyes of 72 infants, and high myopia was present in 23 (17.6%) eyes. Zone I disease was the significant risk factor for unfavorable structural (P < 0.0001), unfavorable visual outcome (P = 0.03), and for high myopia (P < 0.0001). Lower post-conceptional age at treatment was significant for unfavorable structural outcome (P = 0.03) and high myopia (P < 0.0001). Presence of sepsis (P = 0.029) and extraretinal proliferation ≥ 6 hours were significant for unfavorable structural outcome (P = 0.002).
Conclusion: ROP in zone I was the most significant risk factor for all the unfavorable outcomes. Laser-treated ROP infants need long term follow up.
Keywords: refractive outcome; risk factors for unfavorable outcomes; structural outcome; unfavorable outcome; visual outcome.
Similar articles
-
Multicenter trial of cryotherapy for retinopathy of prematurity: natural history ROP: ocular outcome at 5(1/2) years in premature infants with birth weights less than 1251 g.Arch Ophthalmol. 2002 May;120(5):595-9. doi: 10.1001/archopht.120.5.595. Arch Ophthalmol. 2002. PMID: 12003608 Clinical Trial.
-
Refractive outcomes following bevacizumab monotherapy compared with conventional laser treatment: a randomized clinical trial.JAMA Ophthalmol. 2014 Nov;132(11):1327-33. doi: 10.1001/jamaophthalmol.2014.2772. JAMA Ophthalmol. 2014. PMID: 25103848 Clinical Trial.
-
Structural sequelae and refractive outcome 1 year after laser treatment for type 1 prethreshold retinopathy of prematurity in Asian Indian eyes.Indian J Ophthalmol. 2011 Nov-Dec;59(6):423-6. doi: 10.4103/0301-4738.86306. Indian J Ophthalmol. 2011. PMID: 22011484 Free PMC article.
-
Long-term refractive and biometric outcomes following diode laser therapy for retinopathy of prematurity.J AAPOS. 2006 Oct;10(5):454-9. doi: 10.1016/j.jaapos.2006.05.005. J AAPOS. 2006. PMID: 17070482
-
Ocular sequelae in premature infants.Pediatrics. 1993 Dec;92(6):787-90. Pediatrics. 1993. PMID: 8233737 Review.
Cited by
-
Refractive and Visual Outcome after Laser-Treated Retinopathy of Prematurity in Western Romania.Maedica (Bucur). 2016 Jun;11(2):122-129. Maedica (Bucur). 2016. PMID: 28461831 Free PMC article.
-
Long term refractive and structural outcome following laser treatment for zone 1 aggressive posterior retinopathy of prematurity.Oman J Ophthalmol. 2014 Sep;7(3):116-9. doi: 10.4103/0974-620X.142592. Oman J Ophthalmol. 2014. PMID: 25378874 Free PMC article.
-
Outcome of solid-state 532 nm green laser in high-risk retinopathy of prematurity at a tertiary care centre in India.Int Ophthalmol. 2018 Feb;38(1):287-291. doi: 10.1007/s10792-017-0460-3. Epub 2017 Feb 15. Int Ophthalmol. 2018. PMID: 28204988
-
Refractive outcomes following yttrium aluminum garnet laser (532 nm green laser) in severe retinopathy of prematurity.Oman J Ophthalmol. 2022 Nov 2;15(3):331-336. doi: 10.4103/ojo.ojo_315_21. eCollection 2022 Sep-Dec. Oman J Ophthalmol. 2022. PMID: 36760960 Free PMC article.
References
-
- Gilbert C, Rahi J, Eckstein M, Eckstein M, O’Sullivan J, Foster A. Retinopathy of prematurity in middle-income countries. Lancet. 1997;350(9070):12–14. - PubMed
-
- Cryotherapy for Retinopathy of Prematurity Cooperative Group Multicenter trial for cryotherapy for retinopathy of prematurity: Preliminary results. Arch Ophthalmol. 1988;106(4):471–479. - PubMed
-
- DeJonge MH, Ferrone PJ, Trese MT. Diode laser ablation for threshold retinopathy of prematurity: short-term structural outcome. Arch Ophthalmol. 2000;118(3):365–367. - PubMed
-
- Gnanaraj L, Brennan R, Cottrell DG. Retinopathy of prematurity in practice. II: long-term results following treatment for threshold disease. Eye (Lond) 2003;17(2):189–193. - PubMed
-
- Paysse EA, Lindsey JL, Coats DK, Contant CF, Jr, Steinkuller PG. Therapeutic outcomes of cryotherapy versus transpupillary diode laser photocoagulation for threshold retinopathy of prematurity. J AAPOS. 1999;3(4):234–240. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous